Considerations for Common Exclusion Criteria in Real-World (RW) Retrospective Observational Studies in Oncology
Author(s)
Herms L1, Fonseca L1, Patton G1, Espirito J2, Amirian ES2
1Ontada, Irving, TX, USA, 2Ontada, The Woodlands, TX, USA
Presentation Documents
Examining a series of RW studies based on oncology-specific electronic medical records, we identified key dimensions across which these two common exclusion criteria have been differently defined and examined their impact on patient disqualification. Recognizing a trade-off between sample size, bias reduction, and operational efficiency related to the implementation of these criteria, we propose a conceptual framework for the application of these criteria in future studies.
The application of these criteria may have a substantial impact on the internal and external validity of RW studies. Therefore, these criteria should be thoroughly and systematically assessed for each study to ensure selection of the appropriate patient population for the research question being addressed. Customization of eligibility criteria to reduce bias while maximizing sample size and representativeness is a crucially important element of RW study design. Complexity of this task can be reduced for investigators by having a clear and cogent framework for the considerations at play when developing criteria related to trial participation and concomitant primary cancer diagnoses. We encourage investigators to standardize their decision process rather than defaulting to these prevalent, but sometimes restrictive, criteria.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 6, S2 (June 2023)
Code
SA55
Topic
Study Approaches
Topic Subcategory
Electronic Medical & Health Records
Disease
No Additional Disease & Conditions/Specialized Treatment Areas